GlassScriptPhysician profile
Christopher Todd Miller
NPI 1710944939
$2,598.55
in general payments reported to CMS, 2019-2025
22 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $675 · 2020: $188 · 2021: $231 · 2022: $175 · 2023: $553 · 2024: $502 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,329.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $551.77 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $463.88 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $215.50 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $181.40 | 2019-2024 | Camzyos, Eliquis |
| Sanofi-Aventis U.S. LLC | $149.70 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $145.40 | 2024-2025 | Assure Wcd |
| Livanova USA, INC. | $142.52 | 2021 | |
| Alnylam Pharmaceuticals INC. | $91.62 | 2022-2025 | Onpattro |
| Astrazeneca Pharmaceuticals LP | $91.31 | 2019-2025 | Brilinta, Wainua |
| Zoll Circulation INC | $84.84 | 2023 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Amgen INC. | $76.53 | 2019-2023 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $72.46 | 2025 | |
| Merck Sharp & Dohme LLC | $50.45 | 2023 | Verquvo |
| Medtronic Vascular, INC. | $43.93 | 2019 | |
| Amarin Pharma, INC. | $43.16 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.80 | 2023-2024 | Jardiance |
| Mindray Ds USA, INC. | $40.37 | 2025 | A7 Anesthesia System |
| Abiomed | $39.36 | 2020 | |
| Boston Scientific Corporation | $24.63 | 2019 | |
| Abbott Laboratories | $16.03 | 2023 | Diamondback Coronary |
| Nuwellis, INC. | $15.65 | 2019 | |
| Philips North America LLC | $15.24 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.